Phase I Multicenter Trial Combining Nivolumab, Ipilimumab and Hypo-fractionated Radiotherapy for Pretreated Advanced Stage Non-small Cell Lung Cancer Patients
Clinical trial NCT03509584 · TERMINATED
Trial details
- NCT number
- NCT03509584
- Sponsor
- Assistance Publique Hopitaux De Marseille
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-07
- Primary completion
- 2019-07-02
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.